E-LIB Suche - Ergebnisse für: Kito, Hirokazu

1

The Importance of Tablet Formulation on Allergen Release Ki..:

Lund, Kaare ; Kito, Hirokazu ; Skydtsgaard, Mette Blem...
Clinical Therapeutics. 41 (2019) 4 - p. 742-753 , 2019

2

The Effective Allergenic Reactivity of House Dust Mite Subl..:

Kito, Hirokazu ; Du, Weibin ; Nakazawa, Hiroshi..
Biological and Pharmaceutical Bulletin. 42 (2019) 6 - p. 1030-1033 , 2019

Link: https://doi.org/10.1248/..

3

Freeze-dried HDM-SLIT tablets provide maximal HDM allergen ..:

Ohashi-Doi, Katsuyo ; Du, Weibin ; Kito, Hirokazu..
Journal of Allergy and Clinical Immunology. 141 (2018) 2 - p. AB172 , 2018

Link: https://doi.org/10.1016/..

4

Species Difference of (2R,4R)-2-(o-Hydroxyphenyi)-3-(3-Merc..:

NAKATA, Katsuhiko ; IWATANI, Terumichi ; HORIUCHI, Masato...
Japanese Journal of Pharmacology. 40 (1986) 3 - p. 367-372 , 1986

Link: https://doi.org/10.1254/..

5

Influence of diethylmaleate on the formation of bis(methylm..:

MASUKAWA, TOHRU ; NISHIMURA, TATSUYA ; KITO, HIROKAZU.
Journal of Pharmacobio-Dynamics. 6 (1983) 12 - p. 950-953 , 1983

Link: https://doi.org/10.1248/..

6

Degradation of methylmercury by selenium:

Iwata, Heitaroh ; Masukawa, Tohru ; Kito, Hirokazu.
Life Sciences. 31 (1982) 9 - p. 859-866 , 1982

Link: https://doi.org/10.1016/..

7

Involvement of tissue sulfhydryls in the formation of a com..:

Iwata, Heitaroh ; Masukawa, Tohru ; Kito, Hirokazu.
Biochemical Pharmacology. 30 (1981) 23 - p. 3159-3163 , 1981

Link: https://doi.org/10.1016/..

8

Interaction of selenium with methylmercury in the body:

Iwata, Heitaroh ; Masukawa, Tohru ; Kito, Hirokazu.
Japanese Journal of Pharmacology. 31 (1981) - p. 209 , 1981

Link: https://doi.org/10.1016/..

9

Endogenous selenium dependent factors in the liberation of ..:

Iwata, Heitaroh ; Masukawa, Tohru ; Kito, Hirokazu.
Japanese Journal of Pharmacology. 30 (1980) - p. 232 , 1980

Link: https://doi.org/10.1016/..

10

Formation and possible role of bis(methylmercuric) selenide..:

Tohru, Masukawa ; Hirokazu, Kito ; Masaaki, Hayashi.
Biochemical Pharmacology. 31 (1982) 1 - p. 75-78 , 1982

Link: https://doi.org/10.1016/..

11

A Phase II Study of FOLFIRI Plus Ziv-Aflibercept After Trif..:

Matsumoto, Toshihiko ; Yamamoto, Yoshiyuki ; Kotaka, Masahito...
Targeted Oncology. 19 (2024) 2 - p. 181-190 , 2024

Link: https://doi.org/10.1007/..

12

Bone-Regeneration Therapy Using Biodegradable Scaffolds: Ca..:

Aoki, Kaoru ; Ideta, Hirokazu ; Komatsu, Yukiko...
Bioengineering. 11 (2024) 2 - p. 180 , 2024

Link: https://doi.org/10.3390/..

13

Does re-ossification after palliative radiotherapy for spin..:

Kito, Munehisa ; Tsukahara, Yoshinori ; Okamoto, Masanori...
The Spine Journal. 23 (2023) 10 - p. 1540-1548 , 2023

Link: https://doi.org/10.1016/..

14

Muscle strength and functional recovery for soft-tissue sar..:

Tanaka, Atsushi ; Okamoto, Masanori ; Kito, Munehisa...
International Journal of Clinical Oncology. 28 (2023) 7 - p. 922-927 , 2023

Link: https://doi.org/10.1007/..

15

Real-World Treatment Sequencing in Vulnerable Patients with..:

Mitani, Seiichiro ; Kito, Yosuke ; Hino, Kaori...
Targeted Oncology. 18 (2023) 5 - p. 707-715 , 2023

Link: https://doi.org/10.1007/..